Liraglutide
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Novo Nordisk · Phase 3 · Completed · Enrollment 846
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Lira 3.0 mg | 49.9% | 23.4% | n/r | n/r |
| Lira 1.8 mg | 35.6% | 14.4% | n/r | n/r |
| Placebo | 13.8% | 4.3% | n/r | n/r |
Not shown
Every selected arm is drawn.